Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

SARS-CoV-2-specific antibodies, particularly those preventing viral spike receptor binding domain (RBD) interaction with host angiotensin-converting enzyme 2 (ACE2) receptor, can neutralize the virus. It is, however, unknown which features of the serological response may affect clinical outcomes of...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Immunol
Autors principals: Röltgen, Katharina, Powell, Abigail E., Wirz, Oliver F., Stevens, Bryan A., Hogan, Catherine A., Najeeb, Javaria, Hunter, Molly, Wang, Hannah, Sahoo, Malaya K., Huang, ChunHong, Yamamoto, Fumiko, Manohar, Monali, Manalac, Justin, Otrelo-Cardoso, Ana R., Pham, Tho D., Rustagi, Arjun, Rogers, Angela J., Shah, Nigam H., Blish, Catherine A., Cochran, Jennifer R., Jardetzky, Theodore S., Zehnder, James L., Wang, Taia T., Narasimhan, Balasubramanian, Gombar, Saurabh, Tibshirani, Robert, Nadeau, Kari C., Kim, Peter S., Pinsky, Benjamin A., Boyd, Scott D.
Format: Artigo
Idioma:Inglês
Publicat: American Association for the Advancement of Science 2020
Matèries:
Research Articles
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7857392/
https://ncbi.nlm.nih.gov/pubmed/33288645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciimmunol.abe0240
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars